Last reviewed · How we verify
5-Hydroxy-2-Hydroxymethyl-4H-Pyran-4-One (kojic acid)
5-Hydroxy-2-Hydroxymethyl-4H-Pyran-4-One (generic name: kojic acid) is a kojic acid drug. It is currently in unknown development.
Kojic acid works by blocking the enzyme D-amino-acid oxidase, which is involved in the breakdown of certain amino acids.
Kojic acid is a small molecule drug that targets D-amino-acid oxidase. It is classified as a kojic acid and its mechanism of action involves inhibiting the enzyme D-amino-acid oxidase. However, there is limited information available on its commercial status, approved indications, and pharmacokinetic properties. Further research is needed to fully understand its potential as a therapeutic agent. As a result, its clinical use and safety profile remain unclear.
At a glance
| Generic name | kojic acid |
|---|---|
| Drug class | kojic acid |
| Target | D-amino-acid oxidase, Polymerase acidic protein, Tyrosinase |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Think of it like a traffic jam: D-amino-acid oxidase is like a traffic cop that helps break down amino acids. Kojic acid is like a roadblock that prevents the traffic cop from doing its job, which can affect how the body processes certain amino acids.
Approved indications
Common side effects
Key clinical trials
- Effectiveness and Safety of Pigment Solution Program (PSP) as Adjuvant Therapy in Melasma (NA)
- Curcuma Xanthorriza Roxb. 10% Cream for Melasma (EARLY_PHASE1)
- Efficacy of Melanostop Peeling for Improvement of Melasma (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 5-Hydroxy-2-Hydroxymethyl-4H-Pyran-4-One CI brief — competitive landscape report
- 5-Hydroxy-2-Hydroxymethyl-4H-Pyran-4-One updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about 5-Hydroxy-2-Hydroxymethyl-4H-Pyran-4-One
What is 5-Hydroxy-2-Hydroxymethyl-4H-Pyran-4-One?
How does 5-Hydroxy-2-Hydroxymethyl-4H-Pyran-4-One work?
What is the generic name of 5-Hydroxy-2-Hydroxymethyl-4H-Pyran-4-One?
What drug class is 5-Hydroxy-2-Hydroxymethyl-4H-Pyran-4-One in?
What development phase is 5-Hydroxy-2-Hydroxymethyl-4H-Pyran-4-One in?
What does 5-Hydroxy-2-Hydroxymethyl-4H-Pyran-4-One target?
Related
- Drug class: All kojic acid drugs
- Target: All drugs targeting D-amino-acid oxidase, Polymerase acidic protein, Tyrosinase
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing